CAS 269718-84-5

Pardoprunox

Description:

Pardoprunox is a chemical compound that has been investigated primarily for its potential use in treating neurological disorders, particularly Parkinson's disease. It is classified as a dual-action agent, exhibiting both dopamine receptor agonist and serotonin receptor antagonist properties. This dual mechanism may contribute to its therapeutic effects by enhancing dopaminergic signaling while modulating serotonergic pathways, which can help alleviate motor and non-motor symptoms associated with Parkinson's disease. The compound's structure includes specific functional groups that facilitate its interaction with neurotransmitter receptors. Pardoprunox has undergone various phases of clinical trials to assess its efficacy and safety profile, although its development has faced challenges. As with many investigational drugs, understanding its pharmacokinetics, metabolism, and potential side effects is crucial for evaluating its therapeutic potential. Overall, Pardoprunox represents a promising avenue in the search for effective treatments for Parkinson's disease, although further research is necessary to fully establish its clinical utility.

Formula: C₁₂H₁₅N₃O₂

InChI: InChI=1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)

InChI key: InChIKey=YVPUUUDAZYFFQT-UHFFFAOYSA-N

SMILES: O=C1OC2=C(C=CC=C2N1)N3CCN(C)CC3

Synonyms:

• Pardoprunox
• DU 126891
• 2(3H)-Benzoxazolone, 7-(4-methyl-1-piperazinyl)-
• 7-(4-Methyl-1-piperazinyl)-2(3H)-benzoxazolone

Pardoprunox

CAS: 269718-84-5

Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties.

Formula: C₁₂H₁₅N₃O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 233.27

Ref: TM-T1769